Suppliers / Partners Pharmaceuticals

Partners Pharmaceuticals

11 employees Updated 9 July 2026

Partners Pharmaceuticals is an API manufacturer. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Sirolimus US FDA 1

Also appears on these molecule pages

Sirolimus API

Questions about Partners Pharmaceuticals

Does Partners Pharmaceuticals hold a US DMF or a CEP?
Partners Pharmaceuticals holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Partners Pharmaceuticals make?
1 molecule is on record against Partners Pharmaceuticals, including Sirolimus. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Partners Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Biocon shares 1 molecule Apotex shares 1 molecule BrightGene Bio-Medical shares 1 molecule Concord Biotech shares 1 molecule Livzon Group Fuzhou Fuxing Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability